| Literature DB >> 10632052 |
H J Breslin1, M J Kukla, T Kromis, H Cullis, F De Knaep, R Pauwels, K Andries, E De Clercq, M A Janssen, P A Janssen.
Abstract
4,5,6,7-Tetrahydro-5-methylimidazo[4,5,1-jk][1,4]benzodiazepin-2(1 H)-ones (TIBO), 1, have been shown to significantly inhibit HIV-1 replication, as reported in detail in our prior publications. Since our earlier reports, we have modified the TIBO structures 1 by removing the 5-membered ring of 1, generating 1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-ones (TBO), 4, a bicyclic series of compounds. Although compounds 4 possess modest activity when compared to TIBO analogues 1, they clearly demonstrated significant anti-HIV-1 activity.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10632052 DOI: 10.1016/s0968-0896(99)00198-4
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641